11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Background

          In Africa, up to 30% of HIV-infected patients who are clinically eligible for antiretroviral therapy (ART) do not start timely treatment. We assessed the effects of an intervention targeting prevalent health systems barriers to ART initiation on timing and completeness of treatment initiation.

          Methods

          In this stepped-wedge, non-blinded, cluster-randomised controlled trial, 20 clinics in southwestern Uganda were randomly assigned in groups of five clinics every 6 months to the intervention by a computerised random number generator. This procedure continued until all clinics had crossed over from control (standard of care) to the intervention, which consisted of opinion-leader-led training and coaching of front-line health workers, a point-of-care CD4 cell count testing platform, a revised counselling approach without mandatory multiple pre-initiation sessions, and feedback to the facilities on their ART initiation rates and how they compared with other facilities. Treatment-naive, HIV-infected adults (aged ≥18 years) who were clinically eligible for ART during the study period were included in the study population. The primary outcome was ART initiation 14 days after first clinical eligibility for ART. This study is registered with ClinicalTrials.gov, number NCT01810289.

          Findings

          Between April 11, 2013, and Feb 2, 2015, 12 024 eligible patients visited one of the 20 participating clinics. Median CD4 count was 310 cells per μL (IQR 179–424). 3753 of 4747 patients (weighted proportion 80%) in the intervention group had started ART by 2 weeks after eligibility compared with 2585 of 7066 patients (38%) in the control group (risk difference 41·9%, 95% CI 40·1–43·8). Vital status was ascertained in a random sample of 208 patients in the intervention group and 199 patients in the control group. Four deaths (2%) occurred in the intervention group and five (3%) occurred in the control group.

          Interpretation

          A multicomponent intervention targeting health-care worker behaviour increased the probability of ART initiation 14 days after eligibility. This intervention consists of widely accessible components and has been tested in a real-world setting, and is therefore well positioned for use at scale.

          Funding

          National Institute of Allergy and Infectious Diseases (NIAID) and the President’s Emergency Fund for AIDS Relief (PEPFAR).

          Related collections

          Author and article information

          Contributors
          Journal
          101645355
          43213
          Lancet HIV
          Lancet HIV
          The lancet. HIV
          2405-4704
          2352-3018
          18 March 2017
          27 August 2016
          November 2016
          01 November 2017
          : 3
          : 11
          : e539-e548
          Affiliations
          Makerere University, Kampala, Uganda
          Makerere University, Kampala, Uganda
          Makerere University, Kampala, Uganda
          Makerere University, Kampala, Uganda
          Makerere University, Kampala, Uganda
          University of California San Francisco, San Francisco, CA, USA
          University of California San Francisco, San Francisco, CA, USA
          University of California San Francisco, San Francisco, CA, USA
          University of California San Francisco, San Francisco, CA, USA
          University of California San Francisco, San Francisco, CA, USA
          University of California San Francisco, San Francisco, CA, USA
          Makerere University, Kampala, Uganda
          University of California San Francisco, San Francisco, CA, USA
          University of California San Francisco, San Francisco, CA, USA
          Author notes
          Correspondence to: Dr Elvin Geng, University of California San Francisco, San Francisco, CA 94110, USA elvin.geng@ 123456ucsf.edu
          Article
          PMC5408866 PMC5408866 5408866 nihpa814293
          10.1016/S2352-3018(16)30090-X
          5408866
          27658873
          de104439-330e-43e7-bfad-76faf6d3f0ac
          History
          Categories
          Article

          Comments

          Comment on this article